Profile of:

Oleg Nadashkevich

Full name: Oleg Nadashkevich

Current country: Ukraine

Membership level: Associate

Type of membership: Member

Number of publications: 1

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial. Lancet . 2018 Dec 1;392(10162):2378-2387. doi: 10.1016/S0140-6736(18)32463-2 (2018)